Hydrochloric Acid

Hydrochloric Acid

SCHEMBL6219680

CC(=O)C[n+]1ccccc1C.[Cl-]

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.53
SMN1; SMN2 Q16637 3/20 0.48
POLB P06746 2/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
THRB P10828 1/20 0.47
MEN1 O00255 5/20 0.46
LMNA P02545 3/20 0.46
MMP14 P50281 1/20 0.46
CYP2C19 P33261 1/20 0.44
ALDH1A1 P00352 5/20 0.42
KDM4E B2RXH2 6/20 0.39
APOBEC3A P31941 2/20 0.39
APOBEC3G Q9HC16 2/20 0.39
USP2 O75604 2/20 0.39
KEAP1 Q14145 1/20 0.39
NFE2L2 Q16236 1/20 0.39
HPGD P15428 1/20 0.35
HSP90AA1 P07900 1/20 0.34
SLC19A2 O60779 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17847865 0.98 KMT2A (0.54) KMT2ASMN1; SMN2POLBNPC1RAB9A
Hydrochloric Acid SCHEMBL2314704 0.85 KMT2A (0.53) KMT2ASMN1; SMN2POLBNPC1RAB9A
SCHEMBL8120684 0.82 KMT2A (0.54) KMT2ASMN1; SMN2POLBNPC1RAB9A
SCHEMBL19036932 0.80 KMT2A (0.38) KMT2ASMN1; SMN2POLBNPC1RAB9A
Hydrochloric Acid SCHEMBL19031341 0.79 CYP2D6 (0.39) KMT2ASMN1; SMN2POLBNPC1RAB9A
Hydrochloric Acid SCHEMBL1716730 0.79 CYP2D6 (0.39) KMT2ASMN1; SMN2POLBNPC1RAB9A
Hydrochloric Acid SCHEMBL11606548 0.79 KMT2A (0.51) KMT2ASMN1; SMN2POLBNPC1RAB9A
SCHEMBL13394254 0.78 KMT2A (0.70) KMT2ASMN1; SMN2POLBNPC1RAB9A
SCHEMBL19036931 0.77 CYP2D6 (0.40) KMT2ASMN1; SMN2POLBNPC1RAB9A
SCHEMBL1723901 0.77 CYP2D6 (0.40) KMT2ASMN1; SMN2POLBNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537105-A2 SYNTHESIS OF INDOLIZINES Synta Pharmaceuticals Corporation (US) 2005-06-08 EP disclosed
US-20040152897-A1 Synthesis of indolizines SYNTA PHARMACEUTICALS CORP. (US) 2004-08-05 US disclosed
WO-2004024727-A2 SYNTHESIS OF INDOLIZINES SYNTA PHARMACEUTICALS CORP. (US) 2004-03-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040152897-A1 Synthesis of indolizines INMT, IDO1, IDO2 KMT2A 783/4885SMN1; SMN2 3615/4885POLB 1239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.